Upstream Bio (UPB) Operating Leases (2024 - 2026)

Upstream Bio's Operating Leases history runs 3 years deep, the most recent figure standing at $390000.0 for Q1 2026.

• In Q1 2026, Operating Leases fell 60.69% year-over-year to $390000.0; the TTM figure through Mar 2026 stood at $390000.0 (down 60.69% YoY), while the FY2025 annual figure was $549000.0, down 51.42% from the prior year.
• Operating Leases for Q1 2026 stood at $390000.0, down from $549000.0 in the prior quarter.
• The five-year high for Operating Leases was $1.3 million in Q3 2024, with the low at $390000.0 in Q1 2026.
• The 3-year median for Operating Leases is $849000.0 (2025), against an average of $839428.6.
• The sharpest annual moves came in 2025 and 2026: Operating Leases plunged 44.34% in 2025, then tumbled 60.69% in 2026.
• Upstream Bio's Operating Leases stood at $1.1 million in 2024, then sank by 51.42% to $549000.0 in 2025, then retreated by 28.96% to $390000.0 in 2026.
• Business Quant data shows UPB's Operating Leases at $390000.0 in Q1 2026, $549000.0 in Q4 2025, and $703000.0 in Q3 2025.